This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Daniels, J. B.
Right arrow Articles by Besser, T. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daniels, J. B.
Right arrow Articles by Besser, T. E.
Agricola
Right arrow Articles by Daniels, J. B.
Right arrow Articles by Besser, T. E.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, June 2009, p. 3648-3655, Vol. 75, No. 11
0099-2240/09/$08.00+0     doi:10.1128/AEM.02435-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Role of Ceftiofur in Selection and Dissemination of blaCMY-2-Mediated Cephalosporin Resistance in Salmonella enterica and Commensal Escherichia coli Isolates from Cattle{triangledown}

Joshua B. Daniels,1 Douglas R. Call,1 Dale Hancock,2 William M. Sischo,2 Katherine Baker,2 and Thomas E. Besser1*

Department of Veterinary Microbiology and Pathology, Washington State University College of Veterinary Medicine, Pullman, Washington 99164,1 Department of Veterinary Clinical Sciences, Washington State University College of Veterinary Medicine, Pullman, Washington 991642

Received 23 October 2008/ Accepted 3 April 2009

Third-generation cephalosporin resistance of Salmonella and commensal Escherichia coli isolates from cattle in the United States is predominantly conferred by the cephamycinase CMY-2, which inactivates β-lactam antimicrobial drugs used to treat a wide variety of infections, including pediatric salmonellosis. The emergence and dissemination of blaCMY-2--bearing plasmids followed and may in part be the result of selection pressure imposed by the widespread utilization of ceftiofur, a third-generation veterinary cephalosporin. This study assessed the potential effects of ceftiofur on blaCMY-2 transfer and dissemination by (i) an in vivo experimental study in which calves were inoculated with competent blaCMY-2-bearing plasmid donors and susceptible recipients and then subjected to ceftiofur selection and (ii) an observational study to determine whether ceftiofur use in dairy herds is associated with the occurrence and frequency of cephalosporin resistance in Salmonella and commensal E. coli. The first study revealed blaCMY-2 plasmid transfer in both ceftiofur-treated and untreated calves but detected no enhancement of plasmid transfer associated with ceftiofur treatment. The second study detected no association (P = 0.22) between ceftiofur use and either the occurrence of ceftiofur-resistant salmonellosis or the frequency of cephalosporin resistance in commensal E. coli. However, herds with a history of salmonellosis (including both ceftiofur-resistant and ceftiofur-susceptible Salmonella isolates) used more ceftiofur than herds with no history of salmonellosis (P = 0.03) These findings fail to support a major role for ceftiofur use in the maintenance and dissemination of blaCMY-2-bearing plasmid mediated cephalosporin resistance in commensal E. coli and in pathogenic Salmonella in these dairy cattle populations.


* Corresponding author. Mailing address: Department of Veterinary Microbiology and Pathology, Washington State University College of Veterinary Medicine, P.O. Box 647040, Pullman, WA 99164. Phone: (509) 335-6075. Fax: (509) 335-8529. E-mail: tbesser{at}vetmed.wsu.edu

{triangledown} Published ahead of print on 17 April 2009.


Applied and Environmental Microbiology, June 2009, p. 3648-3655, Vol. 75, No. 11
0099-2240/09/$08.00+0     doi:10.1128/AEM.02435-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.